{"generation": 48, "stage": "population", "candidate_idx": 0, "weights": {"risk_aversion": 0.49999950000050003, "herd_behavior": 0.2999997000003, "profit_driven": 0.19999980000020004}, "mean_reward": -0.07541050035102537, "std_reward": 0.0, "mean_abs_error": 0.07541050035102537, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.03, "abs_error": 0.07541050035102537, "reward": -0.07541050035102537, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected to align with the stock's growth potential and low volatility.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 1, "weights": {"risk_aversion": 0.34999965000035, "herd_behavior": 0.14999985000015, "profit_driven": 0.49999950000050003}, "mean_reward": -0.06541050035102536, "std_reward": 0.0, "mean_abs_error": 0.06541050035102536, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.04, "abs_error": 0.06541050035102536, "reward": -0.06541050035102536, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected, though the magnitude would likely be tempered by the stock's already elevated S&P 500 weight.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 2, "weights": {"risk_aversion": 0.2999997000003, "herd_behavior": 0.44999955000045005, "profit_driven": 0.24999975000025002}, "mean_reward": -0.06541050035102536, "std_reward": 0.0, "mean_abs_error": 0.06541050035102536, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.04, "abs_error": 0.06541050035102536, "reward": -0.06541050035102536, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected to align with the stock's growth profile and low volatility.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 3, "weights": {"risk_aversion": 0.34999965000035, "herd_behavior": 0.44999955000045005, "profit_driven": 0.19999980000020004}, "mean_reward": -0.07541050035102537, "std_reward": 0.0, "mean_abs_error": 0.07541050035102537, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.03, "abs_error": 0.07541050035102537, "reward": -0.07541050035102537, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and positive asset growth (Gat=0.306), which are favorable signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected to align with the stock's positive performance indicators and the fund's active growth orientation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 4, "weights": {"risk_aversion": 0.3999996000004001, "herd_behavior": 0.09999990000010002, "profit_driven": 0.49999950000050003}, "mean_reward": -0.07541050035102537, "std_reward": 0.0, "mean_abs_error": 0.07541050035102537, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.03, "abs_error": 0.07541050035102537, "reward": -0.07541050035102537, "best_k": 1, "completion": "\n<think>Given BIIB's high market capitalization relative to book equity and positive profitability, the firm appears fundamentally strong. The fund's current holding is substantial relative to its AUM, and the stock's low beta suggests lower systematic risk. With the fund's large overall exposure and the stock's modest SPX weight, a moderate increase in holding might be expected to align with the firm's solid fundamentals, though the high current position and low trading volume may limit the magnitude of any adjustment.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 5, "weights": {"risk_aversion": 0.34999965000035, "herd_behavior": 0.24999975000025002, "profit_driven": 0.3999996000004001}, "mean_reward": -0.06541050035102536, "std_reward": 0.0, "mean_abs_error": 0.06541050035102536, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.04, "abs_error": 0.06541050035102536, "reward": -0.06541050035102536, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected, though the magnitude would likely be tempered by the stock's already elevated S&P 500 weight.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 6, "weights": {"risk_aversion": 0.34999965000035, "herd_behavior": 0.44999955000045005, "profit_driven": 0.19999980000020004}, "mean_reward": -0.07541050035102537, "std_reward": 0.0, "mean_abs_error": 0.07541050035102537, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.03, "abs_error": 0.07541050035102537, "reward": -0.07541050035102537, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and positive asset growth (Gat=0.306), which are favorable signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected to align with the stock's positive performance indicators and the fund's active growth orientation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 7, "weights": {"risk_aversion": 0.34999965000035, "herd_behavior": 0.44999955000045005, "profit_driven": 0.19999980000020004}, "mean_reward": -0.07541050035102537, "std_reward": 0.0, "mean_abs_error": 0.07541050035102537, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.03, "abs_error": 0.07541050035102537, "reward": -0.07541050035102537, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and positive asset growth (Gat=0.306), which are favorable signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected to align with the stock's positive performance indicators and the fund's active growth orientation.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 8, "weights": {"risk_aversion": 0.3999996000004001, "herd_behavior": 0.3999996000004001, "profit_driven": 0.19999980000020004}, "mean_reward": -0.07541050035102537, "std_reward": 0.0, "mean_abs_error": 0.07541050035102537, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.03, "abs_error": 0.07541050035102537, "reward": -0.07541050035102537, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the firm shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust its position, a modest increase in holding might be expected, though the magnitude would likely be limited by the stock's already substantial S&P 500 weight and the fund's existing exposure.</think>\n<answer>\n{\"holding_log_delta\": -0.03}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 9, "weights": {"risk_aversion": 0.2999997000003, "herd_behavior": 0.2999997000003, "profit_driven": 0.3999996000004001}, "mean_reward": -0.06541050035102536, "std_reward": 0.0, "mean_abs_error": 0.06541050035102536, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.04, "abs_error": 0.06541050035102536, "reward": -0.06541050035102536, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust its position, a modest increase in holding might be expected, though the magnitude would likely be limited by the stock's already substantial S&P 500 weight and the fund's existing exposure.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 10, "weights": {"risk_aversion": 0.2999997000003, "herd_behavior": 0.2999997000003, "profit_driven": 0.3999996000004001}, "mean_reward": -0.06541050035102536, "std_reward": 0.0, "mean_abs_error": 0.06541050035102536, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.04, "abs_error": 0.06541050035102536, "reward": -0.06541050035102536, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust its position, a modest increase in holding might be expected, though the magnitude would likely be limited by the stock's already substantial S&P 500 weight and the fund's existing exposure.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
{"generation": 48, "stage": "population", "candidate_idx": 11, "weights": {"risk_aversion": 0.44999955000045005, "herd_behavior": 0.34999965000035, "profit_driven": 0.19999980000020004}, "mean_reward": -0.06541050035102536, "std_reward": 0.0, "mean_abs_error": 0.06541050035102536, "valid_samples": 1, "invalid_samples": 0, "note": null, "details": [{"id": 741, "quarter": "NA", "permno": 76841, "date": "2016-07-01 00:00:00", "holding_t": 8515.04547, "ticker": "BIIB", "company": "BIOGEN IDEC INC", "profile_strength_mode": "type_mean", "x_risk_mean": 0.0083004769074155, "x_herd_mean": 0.0070097321687576, "x_profit_mean": 0.0811969348655934, "overall_mean": 0.03216904798058883, "y_true": -0.10541050035102537, "pred": -0.04, "abs_error": 0.06541050035102536, "reward": -0.06541050035102536, "best_k": 1, "completion": "\n<think>Given BIIB's current fundamentals, the company shows strong profitability (profit=0.548) and asset growth (Gat=0.306), which are positive signals. The fund's current holding is relatively small compared to its AUM, and the stock's low beta suggests lower systematic risk, potentially allowing for increased allocation without significant risk exposure. Considering the positive fundamentals and the fund's capacity to adjust positions, a modest increase in holding might be expected, though the magnitude would likely be tempered by the stock's already elevated S&P 500 weight.</think>\n<answer>\n{\"holding_log_delta\": -0.04}\n</answer>", "valid": true}]}
